Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
14.37
-0.90 (-5.89%)
Dec 3, 2024, 1:44 PM EST - Market open
Wave Life Sciences Employees
As of December 31, 2023, Wave Life Sciences had 268 total employees, including 266 full-time and 2 part-time employees. The number of employees increased by 16 or 6.35% compared to the previous year.
Employees
268
Change (1Y)
16
Growth (1Y)
6.35%
Revenue / Employee
$200,037
Profits / Employee
-$531,780
Market Cap
2.19B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ardent Health Partners | 23,000 |
| CONMED | 4,000 |
| NeoGenomics | 2,100 |
| Keros Therapeutics | 136 |
| IDEAYA Biosciences | 124 |
| Centessa Pharmaceuticals | 76 |
| CG Oncology | 61 |
| Ligand Pharmaceuticals | 58 |
WVE News
- 18 days ago - Wave Life Sciences to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 21 days ago - Wave Life Sciences Ltd. (WVE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - GlobeNewsWire
- 6 weeks ago - Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst - Seeking Alpha
- 6 weeks ago - This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
- 6 weeks ago - Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans - Benzinga
- 6 weeks ago - Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024 - GlobeNewsWire
- 2 months ago - Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire